Onsdag 7 Maj | 05:39:13 Europe / Stockholm
2025-05-05 11:15:48

In the first quarter, Enzymatica achieved a 30.3 per cent increase in net sales, reaching SEK 12.3 million. The strongest growth was recorded in Sweden and the United Kingdom, while partner-driven sales in other markets remained absent. The company is now accelerating efforts to secure new partnership agreements aimed at expanding ColdZyme's presence in additional international market.

Read the full article at biostock.se:

https://www.biostock.se/en/2025/05/enzymatica-gears-up-for-global-expansion-after-a-strong-first-quarter/

This is a press release from BioStock - Connecting Innovation & Capitalhttps://www.biostock.se